VCTR shorts ease but JP Morgan lifts the ceiling
Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Victory Capital Holdings enters the final stretch before its November 4 earnings with short sellers pulling back slightly from last week's peak, even as JP Morgan becomes the latest firm to raise its price target meaningfully above the current stock price.
The short position has eased a touch from the recent build described in Monday's note. Short interest fell just under 1% on the day to 3.22 million shares, representing roughly 5% of the free float. That is still up about 16% on the week and 14% over the past month, so the drift higher in shorts remains intact. The key change this week is that the pace of accumulation has slowed. Availability remains wide at 312%, meaning roughly three shares are still available for every one borrowed. Cost to borrow is effectively zero at 0.56%. Neither metric signals any squeeze pressure building in the lending market. The short build so far looks like a gradual, considered position rather than a rush to get short ahead of a binary event.
Options positioning tells a modestly bullish story. The put/call ratio has drifted lower to 0.41, slightly below its 20-day average and nearly 1.8 standard deviations below the mean. Calls are outpacing puts by a clear margin. That stands in direct contrast to the short build and suggests the options market is leaning toward a positive earnings reaction rather than hedging against a miss.
The analyst community has spent the past two months nudging targets higher, and that continued this week. JP Morgan raised its target from $101 to $120 on Thursday, maintaining a Neutral rating. Barclays moved from $112 to $121 on Tuesday, also staying at Equal-Weight. Those two moves follow earlier raises from Morgan Stanley (to $115), Goldman Sachs (to $117), and RBC (to $118 with an Outperform). Every recent move has been a raise. None has been an upgrade. The consensus message is that the earnings story is improving but valuation leaves limited room for excitement. The mean target of $123 implies about 13% upside from the current price of $108.60. The PE multiple sits near 13x, and EV/EBITDA is around 8.3x. Both have edged lower over the past week, partly a function of the stock's 3.4% weekly decline.
One standout on the ownership register is worth carrying forward. Amundi filed a Schedule 13D/A on VCTR in April 2025, making it an activist-flagged holder under SEC rules. Its disclosed stake was 4.9% as of the most recent filing last May. The 13D designation is significant: it signals intent beyond passive ownership, though the position has not changed between the two filings and the stock currently shows Amundi holding 4.81% in the institutional data. As always with 13D/G disclosures, stakes are as-last-reported around the 5% threshold, and a holder can fall below 5% without a further filing.
The historical earnings reaction pattern adds context ahead of November 4. The two most recent prints both drove strong moves: the August result produced an 8.2% gain on the day and an 18.2% gain over the following five sessions. That is a pattern where the stock has tended to move significantly and in a positive direction after reporting. How much of that is already reflected in the current options skew, which leans bullish, is the question the market will be working through over the next 16 days.
The key dynamic to watch into November 4 is whether the short position consolidates at current levels or resumes climbing as the print approaches, particularly given that availability remains ample enough to accommodate further building without any friction in the borrow market.
Stocks in this article
See the live data behind this article on ORTEX.
Open VCTR on ORTEX →How this article was generated
- Generated
- 19 Oct 2026, 17:33
- Data as of
- 19 Oct 2026, 17:32
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.